Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $9.82 and traded as low as $9.10. Nxera Pharma shares last traded at $9.15, with a volume of 130 shares.
Nxera Pharma Stock Performance
The business’s 50 day simple moving average is $9.68 and its two-hundred day simple moving average is $9.81.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Featured Stories
- Five stocks we like better than Nxera Pharma
- Investing In Preferred Stock vs. Common Stock
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Stock Sentiment Analysis: How it Works
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- How to Use High Beta Stocks to Maximize Your Investing Profits
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
